Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma. | Sci Adv | 2023 | 37043580 | PubTator, text mining | PubMed |
| Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. | Signal Transduct Target Ther | 2023 | 37041169 | PubTator, text mining | PubMed |
| Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies. | Sci Rep | 2023 | 37012293 | PubTator, text mining | PubMed |
| Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. | JAMA Netw Open | 2023 | 36995716 | PubTator, text mining | PubMed |
| A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis. | bioRxiv | 2023 | 36993405 | PubTator, text mining | PubMed |
| Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling. | Viruses | 2023 | 36992454 | PubTator, text mining | PubMed |
| Viral Vectors in Gene Therapy: Where Do We Stand in 2023? | Viruses | 2023 | 36992407 | PubTator, text mining | PubMed |
| Gene Therapy for Regenerative Medicine. | Pharmaceutics | 2023 | 36986717 | PubTator, text mining | PubMed |
| Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues. | Pharmaceuticals (Basel) | 2023 | 36986536 | PubTator, text mining | PubMed |
| Three-Dimensional Bioprinting of an In Vitro Lung Model. | Int J Mol Sci | 2023 | 36982923 | PubTator, text mining | PubMed |
| Genome-Wide Identification and Characterization of Bovine Fibroblast Growth Factor (FGF) Gene and Its Expression during Adipocyte Differentiation. | Int J Mol Sci | 2023 | 36982739 | PubTator, text mining | PubMed |
| SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update. | Genes (Basel) | 2023 | 36980917 | PubTator, text mining | PubMed |
| Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy. | Cancers (Basel) | 2023 | 36980613 | PubTator, text mining | PubMed |
| Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon. | Cancers (Basel) | 2023 | 36980521 | PubTator, text mining | PubMed |
| Microencapsulated Hepatocytes Differentiated from Human Induced Pluripotent Stem Cells: Optimizing 3D Culture for Tissue Engineering Applications. | Cells | 2023 | 36980206 | PubTator, text mining | PubMed |
| Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review. | Bioengineering (Basel) | 2023 | 36978745 | PubTator, text mining | PubMed |
| HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. | Cell Death Dis | 2023 | 36973255 | PubTator, text mining | PubMed |
| M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study. | Front Oncol | 2023 | 36969032 | PubTator, text mining | PubMed |
| Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment. | Mol Cancer | 2023 | 36966334 | PubTator, text mining | PubMed |
| Network Analysis Reveals the Molecular Bases of Statin Pleiotropy That Vary with Genetic Background. | Microbiol Spectr | 2023 | 36946734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=17